Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Epilepsy
•
General Internal Medicine
•
Neurology
When do you consider switching a generic formulation antiseizure medication to the brand formulation?
Related Questions
Does valproic acid or lithium use in the egg donor pose a risk to the fetus in a surrogate pregnancy?
Would you offer TPO-RAs to a steroid-refractory chronic ITP patient with history of stroke?
How do you adjust the management of epilepsy in patients who are planning to fast?
What types of cardiac conduction abnormalities would lead you to avoid using tricyclic antidepressants?
How would you approach the upfront management of a patient with acute unilateral vision loss with strong clinical risk factors for both cardioembolic stroke and GCA if an expedited MRI is not possible due to the presence of an AICD?
How do you manage a patient who has history consistent with juvenille myoclonic epilepsy (JME) but does not have the classic polyspike pattern on EEG?
How can I incorporate neuromuscular ultrasound into my practice with limited prior experience?
Which factors help you choose between intermittent phenobarbital dosing versus continuous pentobarbital infusion for pharmacological burst suppression in refractory status epilepticus?
How do you approach questions regarding clearance for elective surgery in patients with epilepsy?
Do you prescribe respiratory muscle training (RMT) devices to patients with dysphagia?
